NewYork-Presbyterian Brooklyn Methodist Hospital is located in Park Slope in Brooklyn, New York, between 7th and 8th Avenues, on 6th Street. The academic hospital has 591 beds and provides services to some 42,000 inpatients each year.

There are 651 beds in New York Methodist Hospital.

During the past decade, New York Methodist Hospital conducted 107 clinical trials. In the 10-year time frame, 107 clinical trials started and 62 clinical trials were completed, i.e. on average, 57.9% percent of trials that started reached the finish line to date. In the past 5 years, 43 clinical trials started and 30 clinical trials were completed. i.e. 69.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New York Methodist Hospital" #1 sponsor was "Radiation Therapy Oncology Group" with 49 trials, followed by "Weill Medical College of Cornell University" with 22 trials sponsored, "National Cancer Institute (NCI)" with 15 trials sponsored, "NRG Oncology" with 13 trials sponsored and "New York Presbyterian Brooklyn Methodist Hospital" with 13 trials sponsored. Other sponsors include 119 different institutions and companies that sponsored additional 82 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New York Methodist Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 83 trials as a collaborator, "NRG Oncology" with 18 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 13 trials as a collaborator, "Radiation Therapy Oncology Group" with 7 trials as a collaborator and "Canadian Cancer Trials Group" with 6 trials as a collaborator. Other collaborators include 117 different institutions and companies that were collaborators in the rest 89 trials.

According to Clinical.Site data, the most researched conditions in "New York Methodist Hospital" are "Prostate Cancer" (18 trials), "Heart Failure" (14 trials), "Breast Cancer" (10 trials), "Head and Neck Cancer" (9 trials) and "Sickle Cell Disease" (9 trials). Many other conditions were trialed in "New York Methodist Hospital" in a lesser frequency.

Most popular intervention types in "New York Methodist Hospital" are "Drug" (144 trials), "Radiation" (79 trials), "Other" (51 trials), "Procedure" (39 trials) and "Biological" (26 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (32 trials), "Placebo" (20 trials), "Quality-of-Life Assessment" (16 trials), "Laboratory Biomarker Analysis" (15 trials) and "Questionnaire Administration" (11 trials). Other intervention names were less common.

The vast majority of trials in "New York Methodist Hospital" are 183 trials for "All" genders, 26 trials for "Female" genders and 25 trials for "Male" genders.

Currently, there are NaN active trials in "New York Methodist Hospital". undefined are not yet recruiting, 43 are recruiting, 36 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 118 completed trials in New York Methodist Hospital, 3 suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in New York Methodist Hospital, 15 "Phase 1" clinical trials were conducted, 75 "Phase 2" clinical trials and 94 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 28 trials that are defined as “Not Applicable".